The method of pharmacological correction of experimental hyperlipidemia drug rosuvastatin and magnerot in a combination therapy

摘要

Method pharmacological correction of experimental hyperlipidemia comprising administering a statin, characterized in that in the experiment rats Male Wistar line with hyperlipidemia, against its modeling intraperitoneal injection of Tween-80 at a dose of 200 mg / 100 g body weight once, evaluating the degree of reduction of triglyceride levels, total cholesterol , serum LDL cholesterol in rats, administered intragastrically combination rosuvastatin preparations of 0.66 mg / kg / day and magnerot 100 mg / kg / day.